Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Roche Farma, S.A